In this work, the sonosynthesis of a fluorescent nanocarrier based on iron oxide nanoparticles (mainly magnetite) conjugated with cisplatin, ethylene glycol (EG) and folic acid (FA) is presented. A spectroscopic study on the formation of a complex Fe(II)-FA was performed with the aim of evaluating how the adsorption of FA onto the magnetite takes place. The magnetite ferrofluids were characterized by Raman microspectroscopy, Transmission electron microscopy (TEM), UV-Vis spectroscopy (absorbance and fluorescence), X-ray fluorescence (TXRF) and X-ray diffraction (XRD). The structural analysis shows that Pt is part of the crystal structure of the system together with magnetite. The study also demonstrates that the cisplatin-folate interaction results in a less stable ferrofluid than that obtained in the absence of Pt. However, unlike the latter, the former shows fluorescence.
Introduction
Cisplatin (cis-diaminedichloroplatinum) is currently one of the most effective chemotherapeutic agent used for the treatment of different types of cancer. Its cytotoxic activity is based on the formation of unrepairable platinum-DNA adducts on the purine bases and the activation of various signal transduction pathways that result in cell apoptosis [1] . However, its use is limited, because it displays severe side-effects, as a consequence of its attack on both healthy and cancerous cells.
The other major difficulty with cisplatin is the rapid development of resistance. Cancer cells may increase its capability to repair or tolerate the DNA damage, reduce the expression of the drug transporters [2] and increase production of glutathione, which sequesters cisplatin, leading to a decrease in intracellular drug accumulation [1, 3, 4] .
To overcome these shortcomings, nanocarriers have been designed as drug delivery systems, capable of reducing the toxicity by temporarily passivating the drug during its transport through the bloodstream, preventing its interaction with healthy tissue and increasing tumor uptake through passive or active targeting.
Targeting methods exploit the differences in physical and biological properties between cancer and healthy cells. Passive targeting utilizes the enhanced permeability and retention (EPR) effects [5] [6] [7] . However, nanoparticles can suffer opsonization and subsequent sequestration by macrophages, leading to rapid clearance by the immune system [8] . This can be prevented by modification of nanoparticles surfaces with neutral and hydrophilic biocompatible polymers [e.g., poly(ethylenglycol)] [6, [9] [10] [11] [12] [13] .
Active targeting methods improve delivery efficiency and are based on the specific interaction of a ligand, anchored to the nanocarriers' surface, with a receptor overexpressed on the cancer cell surface. These ligands include antibodies against tumor markers, carbohydrates, vitamins or peptides [14, 15] . Folate (vitamin B9) has been widely applied to tumor targeting thanks to its stability, simple conjugation chemistry, non-immunogenicity and high-affinity binding to the folate receptor, which are highly expressed in many human cancerous cells (e.g., epithelial, ovarian, brain, kidney, breast or lung tumors) [7, 13, 14, 16, 17] .
Among the different types of nanomaterials (liposomes, micelles, dendrimers, silica nanoparticles, inorganic nanoparticles and organic/inorganic hybrid nanoparticles), iron oxide nanoparticles (FeNPs), especially magnetite (Fe 3 O 4 ) and maghemite ( -Fe 2 O 3 ), have been the subject of great interest because of their biocompatible and biodegradable nature and their superparamagnetic behavior, which make them appropriated for biomedical applications, for instance, as contrast agent for magnetic resonance imaging in diagnostics, in cancer therapy hyperthermia, and as magnetic targeted carriers of drugs [18] [19] [20] . Iron oxide is unstable in physiological media so as to prevent aggregation, oxidation, precipitation and loss of magnetic properties, these FeNPs must be stabilized by grafting of or coating with organic species, including surfactants or polymers, such as starch [21] , dextran [22] , PEG [23] , polyvinyl alcohol [24] , oleic acid [25] , albumin [26, 27] , or chitosan [28] , or coating with an inorganic layer, such as, silica [29] or gold [30] . Conjugation of these polymers with a targeting moiety (e.g., folate) and the attachment of cisplatin allow nanoparticles to be used as magnetically targeted drug delivery vehicles.
Nanoparticles must have high drug loading efficiency [31] , which allow to minimize the amount of carrier to be administered, reducing the possible risk of damage caused by the nanoparticle [32] . Moreover, the drug must be efficiently binding to the NP to avoid its unintentional loss during blood circulation [4] .
Physical parameters of the nanoparticles (NPs), such as, size, shape and charge play an important role in obtaining high performance nanoparticles. Thus, the NPs diameter should be between 20 and 150 nm to prevent fast renal clearance and to attenuate off-target uptake by liver, respectively. On the other hand, the optimal surface charge of nanoparticles should be close to neutral or slightly negative to extend lifetime of NPs in the bloodstream and attenuate their uptake by macrophages [11] .
Magnetite NPs can be synthesized using different methods, including, thermal decomposition [33] [34] [35] , co-precipitation [36, 37] or sonochemistry [38] [39] [40] . Thermal decomposition produces highly hydrophobic nanoparticles, of limited utility in biomedical applications [41] . Co-precipitation is a simple method that uses basic aqueous solutions of ferric and ferrous salts and provides hydrophilic NPs in high yields, but with a broad size distribution [42] .
Sonochemical method has proven to be an important tool in the preparation of metal oxides [43] [44] [45] [46] . The use of ultrasound in combination with co-precipitation method facilitates and speeds up the synthesis of NPs of magnetite due to the formation of bubbles acting as microreactors (cavitation). The high temperatures and pressures produced by the ultrasonic waves during cavitation cause the sonolisis of the water and the formation of OH · radicals, highly oxidizing, favoring the formation of magnetite.
In a previous work, our group developed a simple and direct route for the preparation of high performance iron oxide nanoparticles by a sonochemical co-precipitation method, using ultrasound of different frequencies. These new nanocarriers, were composed of a magnetic core and a biocompatible shell of ethylene glycol (EG) with small amounts of cisplatin and folate. A linear dependence of Fe 3+ generation on the sonication time and a decrease in the yield of Fe 3+ when ultrasounds frequency increase, were observed. The mean size of these NPs (21-26 nm) was quasi-independent of frequency. All nanoparticles exhibited ferromagnetic characteristics at room temperature and those containing folate emitted green fluorescence [47] .
In the present work, we report the synthesis of cisplatinloaded EGylated magnetite nanoparticles, functionalized with folic acid (FA). The influence of the pH of the reaction medium on the stability of the nanoparticles was analyzed. The obtained nanoparticles were characterized by Raman spectroscopy, transmission electron microscopy (TEM), total-reflection X-ray (TXRF), fluorescence UV-visible, and X-ray diffraction (XRD).
Materials and methods

Materials
Ferrous sulfate heptahydrate and NaOH were purchased by Panreac, cisplatin and folic acid were purchased by Sigma-Aldrich and ethylene glycol (EG) was purchased by Merck (analysis grade). Deionized water was used for the preparation of all aqueous solutions.
Methods
The ultrasound equipment used in these experiments was a Meinhardt Ultraschalltechnick high-frequency sonicator with one transducer operating at 581 kHz.
The normal Raman spectra were obtained on a Renishaw Raman Microscope System RM2000 equipped with a charge-coupled device (CCD) camera, using a He/Ne 632.8 nm laser as excitation source. The laser beam was focused on the solid sample through the × 50 objective that also collected the scattered radiation. The laser spot on the sample was 1.5 μm. The spectra resolution was 1 cm −1 . All spectra were acquired at room temperature (20 °C). The laser power was adjusted to guarantee no sample decomposition. In Raman spectroscopy, the excessive exposure of iron oxide sample to laser radiation has been shown to generate hematite. This oxidation process is principally due to heating and not to the photo-effect [48] .
For total-reflection X-ray fluorescence (TXRF) measurements, an EXTRA-II Rich and Seifert X-ray fluorescence spectrometer, equipped with Mo radiation was employed. Excitation conditions were 50 kV and 602 μA, and the acquisition time for each spectrum was 500 s.
Particle size and shape were analyzed by transmission electron microscopy (TEM) in a JEOL-2000 FXII electron microscope operated at 200 keV. The samples were prepared by placing one drops of the colloidal solution onto a carboncoated copper grid (200 mesh) and drying it. The mean particle size and distribution were calculated by measuring the internal dimension of at least 100 particles.
The fluorescence spectra were recorded using a Shimadzu spectrofluorimeter RF-5301 PC with a 3 nm bandwidth in excitation and a 1.5 nm bandwidth in emission. Absorption spectra were obtained using a Hewlett-Packard UV-Vis spectrophotometer HP 8453.
To identify the crystalline constituents of the synthesized samples, an X-ray structural analysis was carried out using a Panalytical X'pert PRO Theta/2Theta diffractometer. The diffraction peaks were assigned by comparing with X´pert HighScore Plus program database.
Samples preparation
Synthesis of EG-coated magnetite nanoparticles (FeNPs/EG) and cisplatin-loaded (FeNPs/EG/Pt)
Magnetite nanoparticles were synthesized by sonochemical co-precipitation of iron (II) sulfate (in the absence and presence of cisplatin) in an alkaline aqueous solution, containing ethylene glycol, at pH higher than 10 to minimize formation of maghemite and prevent formation of hematite [49] . The reactions were performed as follows:
To 50 mL of a refrigerated aqueous solution of NaOH (0.04 M) and EG (5% v/v), under sonication, 25 mL of 0.02 M FeSO 4 ·7H 2 O, (alone or containing 5 mg of cisplatin), was added dropwise. The sonication process continued until a black precipitate was obtained. The temperature was maintained below 40 °C.
Functionalization of FeNPs/EG and FeNPs/EG/Pt with folic acid
The above prepared nanoparticles, FeNPs/EG and FeNPs/ EG/Pt, were magnetically collected, and after removing the supernatant, an aqueous basic solution (pH 9 or 13) of 0.013 M folic acid was added (21 and 8.4 mL, respectively). The mixture was heated to 45 °C with stirring for 1.5 h and after this time, was cooled down to room temperature. The nanoparticles were then separated from the supernatant by centrifugation and washed twice with 10 mL of distilled water. Finally, they were dispersed in distilled water and sonicated in an ultrasound bath for 30 min to obtain colloidal suspensions, with a stability that exceeds 1 month.
Results and discussion
UV-Vis absorption and fluorescence spectra of folic acid
With the aim of evaluating how the adsorption of FA onto the magnetite takes place, a spectroscopic study was performed on the formation of a complex Fe(II)-FA.
Firstly, the UV-Vis absorption spectra of FA in aqueous NaOH solution with different concentrations (from 10 −3 to 10 −6 M) were recorded. As can be seen in Fig. 1a , the evolution of the spectra with the pH evidence an equilibrium between two different forms of FA. Thus, the absorption spectrum at lower NaOH concentrations, with two maxima at 350 and 280 nm, would be associated with the form of FA, where the α carboxyl group is deprotonated, while the absorption spectrum at higher NaOH concentration, with three maxima at 366, 283 and 255 nm, would be associated with the fully dissociated FA [50] .
The fluorescence emission spectra of these solutions of FA are depicted in Fig. 1b . A red shift of the emission maximum when going from less to more basic solutions is observed. The band centered at 445 nm is associated with the α-COO − form of FA, while the band centered at 450 nm corresponds with the fully deprotonated FA.
Fe(II)-folic acid complex formation
In Fig. 2a are represented the absorption spectra of FA in aqueous solution of NaOH 10 −5 M with different concentration of Fe(II). When the NaOH concentration is 10 −5 M, the absorption spectra show two isosbestic points, at 393 and 356 nm, indicating the presence of, at least, two different species in equilibrium. One of them should be a complex Fe(II)-FA. Fluorescence emission spectra (Fig. 2b) show a slightly hypsochromic shift, with the maximum going from 445 to 440 nm, when Fe(II) concentration increase. This fact confirms the complex formation. Fig. 1 a UV-Vis absorption spectra of FA (normalized at the first maximum) at different NaOH concentrations. b Fluorescence emission spectra of FA (normalized at the maximum) at different NaOH concentrations The absorption spectra of FA in aqueous solution of NaOH 10 −3 M with different concentration of Fe(II) present a hyperchromic shift when the concentration of Fe(II) increase (Fig. 3a) . This can be related to an increase in turbidity, caused by some kind of Fe colloid, which can be formed due to the high concentration of NaOH in the medium. Thence the fact that the spectrum becomes wider and the appearance of a shoulder between 420 and 450 nm.
On the other hand, the fluorescence emission spectra of these samples show a decrease of intensity when the concentration of Fe(II) increase (Fig. 3b ). This can be caused by the formation of a complex in the ground state (static quenching) or simply, by collisional quenching. Based on the above results, it can conclude that FA complex with Fe(II) when the former has the α-carboxyl group ionized.
Moreover, taking into account that the adsorption of citric acid onto the nanoparticles is most effective when two of its three carboxyl groups are dissociated [36] , it is probable that the FA also complex with Fe(II) when its two carboxyl group are ionized.
Influence of the folic acid solution pH on the stability of functionalized nanoparticles
Since the interaction between FA and magnetite should be similar to that of magnetite with citrate, the functionalization of FeNPs/EG and FeNPs/EG/Pt with FA were carried out at pH 9 and 13. According to the pKa values of FA reported in the literature [51] , at pH 9, only the α-carboxyl group of FA is deprotonated, while at pH 13, both α and β carboxyl groups are ionized. In both cases, stable colloids were obtained, being the most stable those prepared at pH 13. Figure 4a , b presents the TEM images of FeNPs/EG/FA and FeNPs/EG/Pt/FA, respectively. TEM analysis reveals a nearspherical shape of these NPs. FeNPs/EG/FA sample shows a high agglomeration as a consequence of its magnetic properties. The average particle size was smaller in the sample with Pt, with a narrower particle size distribution (8.6 ± 1.9 nm in FeNPs/EG/Pt/FA and 15.8 ± 4.2 nm in FeNPs/EG/FA).
Characterization of nanoparticles TEM
These results indicate that the presence of Pt modifies the size of the NPs, although do not allow to conclude if it is integrated into their structure.
Raman
The Raman spectra of FeNPs/EG/FA and FeNPs/EG/Pt/ FA present a similar Raman profile ( Fig. 5) , with the characteristic bands of magnetite at 670, 500 and 332 cm −1 . The absence of peak (or shoulder) around 700 cm −1 [52] , corresponding to the A 1g mode of vibration of maghemite, indicates that the nanoparticles are mainly composed of magnetite.
On the other hand, the bands above 1000 cm −1 , a broad band peaks at 1345 cm −1 , and two shoulders at 1170 and 1524 cm −1 , point out the presence of folate coating the NPs, according to the assignment of Chourpa et al. [53] and Oblonsky and Devine [54] .
Chourpa et al. [53] state that these bands are not specific of pure magnetite and their intensities become higher for samples kept at ambient conditions for 2 weeks and more. They associated these peaks with the contamination of the samples with carbon-related species. This assignment was confirmed by the disappearance of the band around 1580 cm −1 after an additional washing of the ferrofluids with acetone. Oblonsky and Evine attributed these bands at 1105-1120 cm −1 to short-chain saturated hydrocarbons. The presence of the band at 1345 cm −1 can be related with the asymmetric deformation of CH 2 group, present in both EG and folate. The band at 1524 cm −1 is characteristic of These proposals were corroborated, in a previous work, by dipping a FeNPs/FA sample for 30 and 60 min in a basic aqueous solution of folate (1 mM). An increase of the intensity of the peak at 1560 cm -1 , when dipping time increases, evidence folate adsorption on the NP. (see Fig. 6 in Ref [47] ).
Fluorescence UV-Vis
Surprisingly, the FeNPs/EG/FA sample did not exhibit fluorescence, despite of the presence of FA, a fluorescent species, in the structure. However, FeNPs/EG/Pt/FA showed a fluorescence emission peaks at 440 nm. These results allow us to conclude that the FA species interacting with cisplatin and magnetite is that one with the α-carboxyl group deprotonated. However, it should be mentioned that the colloids containing Pt were less stable than those synthesized in the absence of Pt.
TXRF analysis
A semiquantitative total-reflection X-ray fluorescence analysis was carried out to evaluate the Pt incorporation into the nanoparticles. The results indicate that the Fe/Pt molar ratio is 100/7, which represents an increment in relation to a previous synthesis [47] , where, at best, the Fe/Pt molar ratio was 100/0.41.
On the other hand, comparing the molar ratios of the reactants at the beginning of the reaction to those in the NPs, it can be concluded that approximately 21% of cisplatin molecules have been incorporated into the NPs.
XRD
The crystalline nature of FeNPs/EG/FA and FeNPs/EG/Pt/ FA were investigated by X-ray diffraction. The XRD patterns of the samples are depicted in Fig. 6 . They show a facecentered cubic structure, which may be indexed to either magnetite or maghemite.
It is well known that maghemite exhibits two extra peaks at 23.77° (210) and 26.10° (211) which could be used to distinguish it from magnetite. However, the intensities of these peaks are very weak (5%) to ensure presence of maghemite [56] . In this case, the existence of these two Raman spectra of FeNPs/EG/FA with/without cisplatin peaks is not clear, but according with the Raman spectra, we assume that these nanoparticles are composed mainly by magnetite. In FeNPs/EG/Pt/FA, the reflection of the face-centered cubic structure of the platinum is observed at 40, 46.5, and 67° which correspond to the (111), (200), and (220) reflections, respectively. No other additional phases were observed, so we can conclude that the crystalline structure of these samples is composed of magnetite and platinum.
The particle size of the samples can be estimated using Scherrer's Eq. (1): where D is the crystal size, λ is the wavelength of X-ray (1.5406 Å), θ is the half diffraction angle of the peak and β is the half peak width. The calculated average crystallite sizes were 16.5 and 7.4 nm for FeNPs/EG/FA and FeNPs/ EG/Pt/FA, respectively. Similar values were obtained with the TEM images.
Conclusions
Sonochemical co-precipitation method allow to obtain NPs with a good magnetite/maghemite ratio by controlling the sonication times and the basicity of the medium.
The colloid of magnetite with FA is obtained at a higher NaOH concentration (pH 9-13) being the colloid obtained at pH 13, that is, when FA is α and β deprotonated, the most stable.
The magnetite NPs sonochemically synthesized in the presence of cisplatin, are smaller than those obtained in (1) D = 0.91 cos its absence. They are mainly composed of magnetite and Pt, with a higher Pt/Fe ratio than other NPs synthesized previously.
Only the colloids with Pt into their structure exhibit fluorescence, which makes them suitable for use in biomedicine in addition to as drug delivery carriers.
